The company was founded in 2020 and has built its brand around the concept of metabolic reset - using GLP-1 medications as one component of a broader program that includes nutrition guidance, exercise programming, sleep improvement, and stress management
Katagiri R, Asakura K, Kobayashi S, Suga H, Sasaki S
New Research on GLP-1 Drug Users From IFF and Ingredient Innovation News RESEARCH New IFF report probes GLP-1 trends IFF , a flavor, fragrance, and ingredient company, has released a new report highlighting how the rapidly growing market of GLP-1 medication users is reshaping the sensory experience and nutritional needs associated with eating and drinking
This approach is like treating smoke while ignoring the firetemporarily helpful but ultimately inadequate
Follow the proper administration technique provided by your healthcare provider or pharmacist